Trial Profile
A phase III trial to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic, or mixed episode with or without psychotic features
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2013
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- 01 Oct 2009 Results published in the Journal of Clinical Psychiatry.
- 30 Aug 2008 Results presented at ECNP 2008.
- 31 Aug 2006 Status change